Skip navigation
PR Newswire

Amarantus Provides Comprehensive Corporate Update

SAN FRANCISCO, December 1, 2017 /PRNewswire/ -- Recapitalization plan to use funding mechanisms created under the JOBS Act  Elto Pharma, Inc. preparing to re-start Eltoprazine Phase 2b PD-LID clinical trial  Cutanogen Corporation focusing on identifying new c...